Grand Pharma has a total of 778 patents globally, out of which 459 have been granted. Of these 778 patents, more than 76% patents are active. China is where Grand Pharma has filed the maximum number of patents, followed by United States of America and Europe. Parallelly, China seems to be the main focused R&D centre of Grand Pharma.
Grand Pharma was founded in the year 1995. Company operates as an international pharmaceutical company. It develops anti-tumor and cardiovascular emergency pharmaceutical products, cerebro-cardiovascular intervention medical devices, bio-health products, and more. As of August 2022, Grand Pharma has a market cap of $14.8 Billion.
Do read about some of the most popular patents of Grand Pharma which have been covered by us in this article and also you can find Grand Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Grand Pharma patent portfolio.
How many patents does Grand Pharma have?
Grand Pharma has a total of 778 patents globally. These patents belong to 609 unique patent families. Out of 778 patents, 594 patents are active.
How Many Patents did Grand Pharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Grand Pharma Applications Filed | Grand Pharma Patents Granted |
| 2011 | 25 | 15 |
| 2012 | 28 | 12 |
| 2013 | 36 | 26 |
| 2014 | 25 | 23 |
| 2015 | 28 | 26 |
| 2016 | 84 | 23 |
| 2017 | 48 | 17 |
| 2018 | 84 | 18 |
| 2019 | 93 | 35 |
| 2020 | 86 | 41 |
| 2021 | 77 | 79 |
| 2022 | 9 | 60 |
How many Grand Pharma patents are Alive/Dead?
How Many Patents did Grand Pharma File in Different Countries?
Countries in which Grand Pharma Filed Patents
| Country | Patents |
| China | 593 |
| United States Of America | 38 |
| Europe | 21 |
| Japan | 15 |
| Hong Kong (S.A.R.) | 14 |
| Canada | 9 |
| Australia | 8 |
| Germany | 6 |
| Singapore | 5 |
| Korea (South) | 5 |
| Spain | 4 |
| Denmark | 4 |
| Taiwan | 4 |
| Poland | 4 |
| Brazil | 4 |
| India | 4 |
| Israel | 4 |
| Mexico | 3 |
| Norway | 2 |
| Argentina | 1 |
Where are Research Centres of Grand Pharma Patents Located?
10 Best Grand Pharma Patents
US6347247B1 is the most popular patent in the Grand Pharma portfolio. It has received 402 citations so far from companies like Scimed Life Systems, Cardiac Pacemakers, and Ardian.
Below is the list of 10 most cited patents of Grand Pharma:
| Publication Number | Citation Count |
| US6347247B1 | 402 |
| US6865416B2 | 393 |
| US6516223B2 | 249 |
| US7171264B1 | 177 |
| US6520950B1 | 115 |
| US6567694B2 | 103 |
| US6763264B2 | 92 |
| US6418341B1 | 72 |
| US6451002B1 | 68 |
| US20150297887A1 | 65 |
EXCLUSIVE INSIGHTS COMING SOON!
What are Grand Pharma’s key innovation segments?
What Technologies are Covered by Grand Pharma?
The chart below distributes patents filed by Grand Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Grand Pharma thinks it’s important to protect particular technology inventions.
R&D Focus: How Grand Pharma’s search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Grand Pharma?